AGIO · Company research
Agios Pharmaceuticals, Inc. (AGIO): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 31.72 | $1,938,147,417.18 | 1838500417.18 | 2.7328177835051546 | — | — | 43.3153965175997318 | 1.8889939067329031 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.